Bionano Genomics Announces Issuance of Two U.S. Patents for Novel Methods that Expand Patent Protection for Uses of Nanochannel Arrays in Genome Analysis
April 14, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, April 14, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ software, the...
Bionano Genomics Announces Release of Version 6.2 of its NxClinical Software with Significant New Capabilities for Cancer Research Applications Including HRD Analysis
April 07, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, April 07, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ software, the leading...
Bionano Genomics Announces Publication of a New Study Using OGM Combined with Multiple Analytical Methods Including Single-Cell Analysis as a Comprehensive Molecular Strategy to Characterize the Genomic Variation in B-cell Acute Lymphoblastic Leukemia
April 06, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, April 06, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ software, the leading...
Bionano Genomics Announces Participation at the American Association for Cancer Research Annual Meeting Spotlighting Optical Genome Mapping Applications and Enhanced NxClinical Capabilities for Cancer Research
April 05, 2022 08:00 ET
|
Bionano Genomics
Bionano will exhibit all of its solutions relevant to cancer research: OGM systems, NxClinical software and expert laboratory servicesExhibitor Theater presentation will share the latest OGM research...
Bionano Genomics Announces Speaker Lineup for 2022 China Symposium
March 25, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, March 25, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ software, the...
Bionano Genomics to Present at the 2022 Maxim Virtual Growth Conference
March 23, 2022 16:14 ET
|
Bionano Genomics
SAN DIEGO, March 23, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™ software, the leading...
Bionano Genomics Announces its Participation at the American College of Medical Genetics and Genomics Annual Clinical Genetics Meeting with Six Posters and All of its On-Market Solutions on Display
March 23, 2022 08:00 ET
|
Bionano Genomics
Bionano is back in-person at the ACMG annual meeting – this time as ONE COMPANY with MORE SOLUTIONSFor the first time, Bionano will exhibit all of its products and solutions with its combined...
Bionano Genomics Announces Publication of Comprehensive Validation of Optical Genome Mapping for Hematologic Neoplasms
March 18, 2022 08:00 ET
|
Bionano Genomics
Key findings from evaluation of 59 Heme Samples and 10 Controls: OGM detected 162/164 SVs detected by standard cytogenetics methods of karyotyping and FISHOGM detected chromosomal aberrations...
Bionano Genomics to Present at the 32nd Annual Oppenheimer Healthcare Conference
March 08, 2022 17:00 ET
|
Bionano Genomics
SAN DIEGO, March 08, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, a leading software...
Bionano Genomics Appoints Dr. Aleks Rajkovic to its Board of Directors
March 07, 2022 08:00 ET
|
Bionano Genomics
SAN DIEGO, March 07, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), pioneer of optical genome mapping (OGM) solutions on the Saphyr® system and provider of NxClinical™, the leading...